These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35686696)

  • 1. Improved pasireotide response in USP8 mutant corticotroph tumours in vitro.
    Albani A; Perez-Rivas LG; Tang S; Simon J; Lucia KE; Colón-Bolea P; Schopohl J; Roeber S; Buchfelder M; Rotermund R; Flitsch J; Thorsteinsdottir J; Herms J; Stalla G; Reincke M; Theodoropoulou M
    Endocr Relat Cancer; 2022 Aug; 29(8):503-511. PubMed ID: 35686696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease.
    Hayashi K; Inoshita N; Kawaguchi K; Ibrahim Ardisasmita A; Suzuki H; Fukuhara N; Okada M; Nishioka H; Takeuchi Y; Komada M; Takeshita A; Yamada S
    Eur J Endocrinol; 2016 Feb; 174(2):213-26. PubMed ID: 26578638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USP8 inhibitor RA-9 reduces ACTH release and cell growth in tumor corticotrophs.
    Treppiedi D; Di Muro G; Marra G; Barbieri AM; Mangili F; Catalano R; Serban A; Ferrante E; Locatelli M; Lania AG; Arosio M; Spada A; Peverelli E; Mantovani G
    Endocr Relat Cancer; 2021 Jun; 28(8):573-582. PubMed ID: 34086599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted analysis of Ubiquitin-Specific Peptidase (USP8) in a population of Iranian people with Cushing's disease and a systematic review of the literature.
    Hashemi-Madani N; Cheraghi S; Emami Z; Mehrjardi AZ; Kaynama MR; Khamseh ME
    BMC Endocr Disord; 2024 Jun; 24(1):86. PubMed ID: 38862897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pasireotide-resistant Refractory Cushing's Disease without Somatostatin Receptor 5 Expression.
    Mizuno T; Inoshita N; Fukuhara N; Tatsushima K; Takeshita A; Yamada S; Nishioka H; Takeuchi Y
    Intern Med; 2022 Mar; 61(5):679-685. PubMed ID: 34471015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease.
    Perez-Rivas LG; Theodoropoulou M; Ferraù F; Nusser C; Kawaguchi K; Stratakis CA; Faucz FR; Wildemberg LE; Assié G; Beschorner R; Dimopoulou C; Buchfelder M; Popovic V; Berr CM; Tóth M; Ardisasmita AI; Honegger J; Bertherat J; Gadelha MR; Beuschlein F; Stalla G; Komada M; Korbonits M; Reincke M
    J Clin Endocrinol Metab; 2015 Jul; 100(7):E997-1004. PubMed ID: 25942478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. USP8: a novel therapeutic target for Cushing's disease.
    Jian F; Cao Y; Bian L; Sun Q
    Endocrine; 2015 Nov; 50(2):292-6. PubMed ID: 26162929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P720R USP8 Mutation Is Associated with a Better Responsiveness to Pasireotide in ACTH-Secreting PitNETs.
    Treppiedi D; Marra G; Di Muro G; Esposito E; Barbieri AM; Catalano R; Mangili F; Bravi F; Locatelli M; Lania AG; Ferrante E; Indirli R; Nozza E; Arlati F; Spada A; Arosio M; Mantovani G; Peverelli E
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Spectrum of USP8 Pathogenic Variants in Cushing's Disease.
    Rebollar-Vega RG; Zuarth-Vázquez JM; Hernández-Ramírez LC
    Arch Med Res; 2023 Dec; 54(8):102899. PubMed ID: 37925320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decoding the genetic basis of Cushing's disease: USP8 in the spotlight.
    Theodoropoulou M; Reincke M; Fassnacht M; Komada M
    Eur J Endocrinol; 2015 Oct; 173(4):M73-83. PubMed ID: 26012588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of Cushing's disease: from the lab to clinical practice.
    Theodoropoulou M; Reincke M
    Pituitary; 2022 Oct; 25(5):689-692. PubMed ID: 35852754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. USP8 Mutations and Cell Cycle Regulation in Corticotroph Adenomas.
    Martins CS; Camargo RC; Coeli-Lacchini FB; Saggioro FP; Moreira AC; de Castro M
    Horm Metab Res; 2020 Feb; 52(2):117-123. PubMed ID: 32053843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. USP8, USP48, and BRAF mutations differ in their genotype-phenotype correlation in Asian Indian patients with Cushing's disease.
    Abraham AP; Pai R; Beno DL; Chacko G; Asha HS; Rajaratnam S; Kapoor N; Thomas N; Chacko AG
    Endocrine; 2022 Feb; 75(2):549-559. PubMed ID: 34664215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the deubiquitinase gene USP8 cause Cushing's disease.
    Reincke M; Sbiera S; Hayakawa A; Theodoropoulou M; Osswald A; Beuschlein F; Meitinger T; Mizuno-Yamasaki E; Kawaguchi K; Saeki Y; Tanaka K; Wieland T; Graf E; Saeger W; Ronchi CL; Allolio B; Buchfelder M; Strom TM; Fassnacht M; Komada M
    Nat Genet; 2015 Jan; 47(1):31-8. PubMed ID: 25485838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. USP8 mutations in corticotroph adenomas determine a distinct gene expression profile irrespective of functional tumour status.
    Bujko M; Kober P; Boresowicz J; Rusetska N; Paziewska A; Dąbrowska M; Piaścik A; Pękul M; Zieliński G; Kunicki J; Bonicki W; Ostrowski J; Siedlecki JA; Maksymowicz M
    Eur J Endocrinol; 2019 Dec; 181(6):615-627. PubMed ID: 31581124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic
    Pérez-Rivas LG; Theodoropoulou M; Puar TH; Fazel J; Stieg MR; Ferraù F; Assié G; Gadelha MR; Deutschbein T; Fragoso MC; Kusters B; Saeger W; Honegger J; Buchfelder M; Korbonits M; Bertherat J; Stalla GK; Hermus AR; Beuschlein F; Reincke M
    Eur J Endocrinol; 2018 Jan; 178(1):57-63. PubMed ID: 28982703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of Cushing's disease: an update.
    Perez-Rivas LG; Reincke M
    J Endocrinol Invest; 2016 Jan; 39(1):29-35. PubMed ID: 26208471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
    Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
    Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. USP8 mutation in Cushing's disease.
    Huang C; Shi Y; Zhao Y
    Oncotarget; 2015 Jul; 6(21):18240-1. PubMed ID: 26285834
    [No Abstract]   [Full Text] [Related]  

  • 20. Responsiveness to DDAVP in Cushing's disease is associated with USP8 mutations through enhancing AVPR1B promoter activity.
    Shichi H; Fukuoka H; Kanzawa M; Yamamoto M; Yamamoto N; Suzuki M; Urai S; Matsumoto R; Kanie K; Fujita Y; Bando H; Iguchi G; Inoshita N; Yamada S; Takahashi Y; Ogawa W
    Pituitary; 2022 Jun; 25(3):496-507. PubMed ID: 35451730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.